{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2018"],"data_sharing_plan":["IPD Sharing (as of October 2020): No"],"condition":["Lymphoma, Large B-Cell, Diffuse","Renal Cell Carcinoma (RCC)","Advanced solid tumor","Microsatellite Instability","Carcinoma","Triple Negative Breast Neoplasms","Mesothelioma","Urothelial Carcinoma","Triple-negative Breast Cancer","Endometrial Neoplasms","Lung Neoplasms","Carcinoma, Merkel Cell","Ovarian Cancer","Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])","Squamous Cell Carcinoma of Head and Neck","Hepatocellular Carcinoma","Small Cell Lung Cancer (SCLC)","Cervical Cancer","Melanoma","Small Cell Lung Carcinoma","Diffuse Large B-cell Lymphoma","Microsatellite Instability (MSI)-High Endometrial Cancer","Merkel Cell Carcinoma","MSI-high Colorectal Cancer","Melanoma (Uveal Melanoma Excluded)","Esophageal Cancer","Squamous Cell Carcinoma of the Head and Neck (SCCHN)","Non-small Cell Lung Cancer (NSCLC)"],"disease":["Lymphoma, Large B-cell, Diffuse","Squamous Cell Carcinoma Of The Head And Neck (scchn)","Microsatellite Instability","Carcinoma","Triple Negative Breast Neoplasms","Mesothelioma","Urothelial Carcinoma","Triple-negative Breast Cancer","Endometrial Neoplasms","Microsatellite Instability (msi)-high Endometrial Cancer","Lung Neoplasms","Carcinoma, Merkel Cell","Ovarian Cancer","Gastric Cancer (including Stomach And Gastroesophageal Junction [gej])","Advanced Solid Tumor","Hepatocellular Carcinoma","Cervical Cancer","Melanoma","Small Cell Lung Carcinoma","Melanoma (uveal Melanoma Excluded)","Diffuse Large B-cell Lymphoma","Merkel Cell Carcinoma","Non-small Cell Lung Cancer (nsclc)","Small Cell Lung Cancer (sclc)","Renal Cell Carcinoma (rcc)","Squamous Cell Carcinoma Of Head And Neck","Msi-high Colorectal Cancer","Esophageal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2273916"],"location":["United States"],"study_start_month":["6"],"keyword":["LAG-3","Lymphocyte activation gene (LAG)","Relapsed/refractory DLCBL","Metastatic solid tumor"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies","description":"The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.","dates":{"creation":"2018-06-15"},"accession":"2273916","cross_references":{"ClinicalTrials___gov":["NCT03538028"]}}